Health and Safety | Op-Eds & Articles | Publications

Lost lives the real costs of regulator overreach

By Henry I. Miller, Gregory Conko,
May 4, 2013

FTC Drug Meddling Would Needlessly Push Pharmaceutical Costs Higher

By Gregory Conko,
March 24, 2013

The Ripple Effects of Flawed Agbiotech Regulation

By Gregory Conko, Henry I. Miller,
January 9, 2013

Senator Durbin is wrong on energy drinks ban

By Michelle Minton,
November 28, 2012

Free Speech for Big Pharma

By Henry I. Miller, Gregory Conko,
November 14, 2012

A Lack of Government Transparency: The Devil In The Detailing

By Henry I. Miller,
October 24, 2012

A Losing Proposition on Food Labeling

By Gregory Conko, Henry I. Miller,
October 11, 2012

"Genetically Engineered" In California: A Food Label We Don't Need

By Gregory Conko, Henry I. Miller,
October 8, 2012

Labeling Of Genetically Engineered Foods Is A Losing Proposition

By Henry I. Miller, Gregory Conko,
September 12, 2012

FDA rules won't do much good

By Gregory Conko, Ryan Young,
August 23, 2012

More FDA Control Does Not Mean More Safety

By Michelle Minton,
July 18, 2012

The American Revolution Comes to a Pitiful Close

By Matt Patterson,
July 4, 2012

Three Quick Thoughts on the Health Care Ruling

By Ryan Young,
June 28, 2012

Global Governments' Growing Embrace of Big Pharma

By William Frezza,
June 25, 2012

Does Thimerosal Prevent Autism? Epidemiology Gone Wild

By William Frezza,
June 20, 2012

High Price of Cheap Drug Imports

By Gregory Conko,
May 18, 2012

ObamaCare's Killer Device Tax

By Henry I. Miller,
May 11, 2012

The Off-Label Drug War of Words

By William Frezza,
May 2, 2012

Mayo v. Prometheus and Diagnostic Patents: What Does the Supreme Court Decision Really Mean?

By Gregory Conko,
April 4, 2012

The Orphan Drug Conundrum

By William Frezza,
April 3, 2012